Therefore, GLP-1 may reduce the likelihood of non-alcoholic fatty liver disease (NAFLD) in individuals with T2DM by directly interacting with hepatic GLP-1 receptors. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.